Torrent Pharmaceuticals is planning to release oral and injectable versions of the weight loss drug, semaglutide, following the expiration of Novo Nordisk's patent.

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...